ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics.
Moriggi M, Giussani M, Torretta E, Capitanio D, Sandri M, Leone R, De Palma S, Vasso M, Vozzi G, Tagliabue E, Gelfi C.
Proteomics. 2018 Oct 24:e1800278. doi: 10.1002/pmic.201800278.

2018

Extracellular matrix proteins as diagnostic markers of breast carcinoma.
Giussani M, Landoni E, Merlino G, Turdo F, Veneroni S, Paolini B, Cappelletti V, Miceli R, Orlandi R, Triulzi T, Tagliabue E.
J Cell Physiol. 2018 Mar 9.
doi: 10.1002/jcp.26513.

2018

Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer. Merlino G, Miodini P, Callari M, D'Aiuto F, Cappelletti V,
Daidone MG.

Mol Oncol. 2017 Jul 3.
doi: 10.1002/1878-0261.12107.

2017

Persistent immune stimulation exacerbates genetically-driven myeloproliferative disorders via stromal remodeling.
Tripodo C, Burocchi A, Piccaluga PP, Chiodoni C, Portararo P, Cappetti B, Botti L, Gulino A, Isidori A, Liso A, Visani G,
Martelli MP, Falini B, Pandolfi PP, Colombo MP, Sangaletti S
Cancer Res.
2017 Jul 1;77(13):3685-3699.
doi: 10.1158/0008-5472.
CAN-17-1098. Epub 2017 May 23

2017

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
Di Modica M, Regondi V, Sandri M, Iorio MV, Zanetti A, Tagliabue E, Casalini P, Triulzi T.
Cancer Lett. 2017 Jan 1;384:94-100. doi: 10.1016/j.canlet.2016.09.013.
Epub 2016 Sep 28.

2017

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
Bulla R, Tripodo C, Rami D, Ling GS, Agostinis C, Guarnotta C, Zorzet S, Durigutto P, Botto M, Tedesco F.
Nat Commun. 2016 Feb 1;7:10346. doi: 10.1038/ncomms10346.

2016

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer.
Merlino G, Miodini P, Paolini B, Carcangiu ML, Gennaro M, Dugo M, Daidone MG, Cappelletti V.
Microarrays (Basel). 2016 May 18;5(2). pii: E10. doi: 10.3390/microarrays5020010.

2016

Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
Sangaletti S, Tripodo C, Santangelo A, Castioni N, Portararo P, Gulino A, Botti L, Parenza M, Cappetti B, Orlandi R, Tagliabue E, Chiodoni C, Colombo MP.
Cell Rep. 2016 Sep 27;17(1):233-48. doi: 10.1016/j.celrep.2016.08.075.

2016

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics.
Moriggi M, Giussani M, Torretta E, Capitanio D, Sandri M, Leone R, De Palma S, Vasso M, Vozzi G, Tagliabue E, Gelfi C.
Proteomics. 2018 Oct 24:e1800278. doi: 10.1002/pmic.201800278.

2018

RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis.
Strauss L, Sangaletti S, Consonni FM, Szebeni G, Morlacchi S, Totaro MG, Porta C, Anselmo A, Tartari S, Doni A, Zitelli F, Tripodo C, Colombo MP, Sica A.
Cancer Cell. 2015 Aug 10;28(2):253-69. doi: 10.1016/j.ccell.2015.07.006.

2015

miR-30e* is an independent subtype-specific prognostic marker in breast cancer.
D'Aiuto F, Callari M, Dugo M, Merlino G, Musella V, Miodini P, Paolini B, Cappelletti V,
Daidone MG.
Br J Cancer.
2015 Jul 14;113(2):290-8.
doi: 10.1038/bjc.2015.206.
Epub 2015 Jun 9.

2015

Circulating Biomarkers for Prediction of Treatment Response.
Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M, Daidone MG.
J Natl Cancer Inst Monogr. 2015 May;2015(51):60-3. doi: 10.1093/jncimonographs/lgv006.

2015

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.
Oncotarget. 2015 Feb 10;6(4):2315-30.

2015

Gene expression profiling of circulating tumor cells in breast cancer.
Fina E, Callari M, Reduzzi C, D'Aiuto F, Mariani G, Generali D, Pierotti MA, Daidone MG, Cappelletti V.
Clin Chem. 2015 Jan;61(1):278-89. doi: 10.1373/clinchem.2014.229476.
Epub 2014 Nov 19.

2015

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
Giussani M, Merlino G, Cappelletti V, Tagliabue E, Daidone MG
Semin Cancer Biol. 2015 Dec;35:3-10. doi: 10.1016/j.semcancer.2015.09.012. Epub 2015 Sep 28.

2015

SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.
Vitali C, Bassani C, Chiodoni C, Fellini E, Guarnotta C, Miotti S, Sangaletti S, Fuligni F, De Cecco L, Piccaluga PP, Colombo MP, Tripodo C
Cancer Res. 2015 Jun 1;75(11):2387-99. doi: 10.1158/0008-5472.CAN-14-3625. Epub 2015 Apr 9.

2015

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.
Triulzi T, Ratti M, Tortoreto M, Ghirelli C, Aiello P, Regondi V, Modica MD, Cominetti D, Carcangiu ML, Moliterni A, Balsari A, Casalini P, Tagliabue E
Int J Cancer.
2014 Jun 15;134(12):2789-97.
doi: 10.1002/ijc.28608.
Epub 2013 Nov 30

2014

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer.
Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, Radice P, Manoukian S, Peissel B, Daidone MG, Gariboldi M, Pierotti MA
PLoS One. 2014 Jan 27;9(1):e87039. doi: 10.1371/journal.pone.0087039.
eCollection 2014.

2014

Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.
Sangaletti S, Tripodo C, Portararo P, Dugo M, Vitali C, Botti L, Guarnotta C, Cappetti B, Gulino A, Torselli I, Casalini P, Chiodoni C, Colombo MP
Oncoimmunology. 2014 Jun 5;3:e28989. eCollection 2014.

2014

Osteopontin shapes immune suppression in the metastatic niche.
Sangaletti S, Tripodo C, Sandri S, Torselli I, Vitali C, Ratti C, Botti L, Burocchi A, Porcasi R, Tomirotti A, Colombo MP, Chiodoni C
Cancer Res. 2014 Sep 1;74(17):4706-19. doi: 10.1158/0008-5472.CAN-13-3334. Epub 2014 Jul 17.

2014

Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma.
Sangaletti S, Tripodo C, Vitali C, Portararo P, Guarnotta C, Casalini P, Cappetti B, Miotti S, Pinciroli P, Fuligni F, Fais F, Piccaluga PP, Colombo MP
Cancer Discov. 2014 Jan;4(1):
110-29. doi: 10.1158/2159-8290.
CD-13-0276. Epub 2013 Nov 4.

2014

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma.
Franco G, Guarnotta C, Frossi B, Piccaluga PP, Boveri E, Gulino A, Fuligni F, Rigoni A, Porcasi R, Buffa S, Betto E, Florena AM, Franco V, Iannitto E, Arcaini L, Pileri SA, Pucillo C, Colombo MP, Sangaletti S, Tripodo C
Blood. 2014 Mar 20;123(12):1836-49. doi: 10.1182/
blood-2013-04-497271.
Epub 2014 Jan 22.

2014

Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
Callari M, Musella V, Di Buduo E, Sensi M, Miodini P, Dugo M, Orlandi R, Agresti R, Paolini B, Carcangiu ML, Cappelletti V, Daidone MG. 
Mol Oncol. 2014 Oct;8(7):1278-89.
doi: 10.1016/
j.molonc.2014.04.010.
Epub 2014 May 4.

2014

A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samples.
Appierto V, Callari M, Cavadini E, Morelli D, Daidone MG, Tiberio P.
Bioanalysis.
2014 May;6(9):1215-26.
doi: 10.4155/bio.13.344.

2014

Feasibility of circulating miRNA microarray analysis from archival plasma samples. 
Callari M, Tiberio P, De Cecco L, Cavadini E, Dugo M, Ghimenti C, Daidone MG, Canevari S,
Appierto V. 
Anal Biochem.
2013 Jun 15;437(2):123-5.
doi: 10.1016/j.ab.2013.03.002.
Epub 2013 Mar 13.

2013

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
Triulzi T, Casalini P, Sandri M, Ratti M, Carcangiu ML, Colombo MP, Balsari A, Ménard S, Orlandi R, Tagliabue E. 
PLoS One. 2013;8(2):e56761. doi: 10.1371/journal.pone.0056761. Epub 2013 Feb 18.

2013

Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. 
Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M, Franco G, Chiodoni C, Sciandra M, Miotti S, Calvaruso G, Carè A, Florena AM, Scotlandi K, Orazi A, Pileri SA, Colombo MP.
Blood.
2012 Oct 25;120(17):3541-54.
doi: 10.1182/
blood-2011-12-398537.
Epub 2012 Sep 5.

2012

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Progetto finanziato con

il contributo Airc 5x1000

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié